Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemia. Issue 4 (3rd April 2018) - Andritsos, Leslie A.; Grieselhuber, Nicole R.; Anghelina, Mirela; Rogers, Kerry A.; Roychowdhury, Sameek; Reeser, Julie W.; Timmers, Cynthia D.; Freud, Aharon G.; Blachly, James S.; Lucas, David M.; Lozanski, Gerard; Jones, Jeffrey A.; et al.